C WorldWide Group Holding A S Has $13.91 Million Holdings in Waters Co. (NYSE:WAT)

C WorldWide Group Holding A S cut its holdings in Waters Co. (NYSE:WAT) by 75.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,496 shares of the medical instruments supplier’s stock after selling 117,280 shares during the period. C WorldWide Group Holding A S owned about 0.06% of Waters worth $13,910,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Kennebec Savings Bank acquired a new position in shares of Waters in the third quarter valued at $33,000. Bank of Jackson Hole Trust acquired a new position in shares of Waters in the fourth quarter valued at $34,000. Ashton Thomas Securities LLC acquired a new position in shares of Waters in the third quarter valued at $35,000. Fortitude Family Office LLC increased its holdings in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares during the last quarter. Finally, R Squared Ltd acquired a new position in shares of Waters in the fourth quarter valued at $63,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Down 1.7 %

WAT stock opened at $374.24 on Monday. The stock has a market capitalization of $22.22 billion, a P/E ratio of 34.94, a price-to-earnings-growth ratio of 3.79 and a beta of 1.01. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. Waters Co. has a 12 month low of $279.24 and a 12 month high of $423.56. The firm has a 50-day moving average price of $388.85 and a 200-day moving average price of $366.15.

Waters (NYSE:WAT) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, equities research analysts anticipate that Waters Co. will post 12.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. StockNews.com raised shares of Waters from a “hold” rating to a “buy” rating in a research report on Monday, February 17th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price for the company in a research report on Friday, January 10th. UBS Group boosted their target price on shares of Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research report on Thursday, February 13th. TD Cowen boosted their target price on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Finally, Stifel Nicolaus boosted their target price on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Ten analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $390.40.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.